Redmile Group’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-323,265
| Closed | -$2.1M | – | 85 |
|
|
2019
Q1 | $2.1M | Buy |
+323,265
| New | +$2.1M | 0.06% | 65 |
|
|
2017
Q4 | – | Sell |
-332,310
| Closed | -$2.08M | – | 72 |
|
|
2017
Q3 | $2.08M | Hold |
332,310
| – | – | 0.1% | 57 |
|
|
2017
Q2 | $2.04M | Buy |
332,310
+192,067
| +137% | +$1.18M | 0.12% | 53 |
|
|
2017
Q1 | $1.03M | Buy |
140,243
+103,500
| +282% | +$759K | 0.07% | 56 |
|
|
2016
Q4 | $77K | Sell |
36,743
-150,867
| -80% | -$316K | 0.01% | 48 |
|
|
2016
Q3 | $565K | Buy |
187,610
+159,200
| +560% | +$479K | 0.04% | 43 |
|
|
2016
Q2 | $79K | Buy |
28,410
+8,700
| +44% | +$24.2K | 0.01% | 52 |
|
|
2016
Q1 | $58K | Buy |
19,710
+3,100
| +19% | +$9.12K | 0.01% | 45 |
|
|
2015
Q4 | $41K | Buy |
+16,610
| New | +$41K | ﹤0.01% | 56 |
|